TIAA CREF Investment Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$731K Buy
138,934
+5,721
+4% +$39.7K ﹤0.01% 2451
2018
Q4
$871K Hold
133,213
﹤0.01% 2334
2018
Q3
$2.29M Sell
133,213
-17,976
-12% -$267K ﹤0.01% 2057
2018
Q2
$2.11M Sell
151,189
-2,129
-1% -$36K ﹤0.01% 2141
2018
Q1
$2.35M Buy
153,318
+15,173
+11% +$217K ﹤0.01% 2022
2017
Q4
$1.59M Sell
138,145
-12,460
-8% -$186K ﹤0.01% 2252
2017
Q3
$2.86M Sell
150,605
-6,679
-4% -$137K ﹤0.01% 1955
2017
Q2
$3.79M Sell
157,284
-4,468
-3% -$98K ﹤0.01% 1777
2017
Q1
$3.21M Sell
161,752
-6,804
-4% -$152K ﹤0.01% 1859
2016
Q4
$4.06M Sell
168,556
-2,746
-2% -$76.4K ﹤0.01% 1738
2016
Q3
$4.76K Buy
171,302
+4,755
+3% +$126K ﹤0.01% 1643
2016
Q2
$4.06M Buy
166,547
+23,340
+16% +$662K ﹤0.01% 1689
2016
Q1
$4.81M Buy
143,207
+3,217
+2% +$101K ﹤0.01% 1532
2015
Q4
$4.18M Buy
139,990
+1,618
+1% +$54.5K ﹤0.01% 1685
2015
Q3
$4.36M Sell
138,372
-97,662
-41% -$4.77M ﹤0.01% 1625
2015
Q2
$11.4M Buy
236,034
+99,294
+73% +$4.18M 0.01% 1061
2015
Q1
$5.93M Buy
136,740
+2,570
+2% +$92.3K ﹤0.01% 1511
2014
Q4
$3.53M Sell
134,170
-5,333
-4% -$117K ﹤0.01% 1870
2014
Q3
$2.48M Sell
139,503
-1,485
-1% -$30.3K ﹤0.01% 2097
2014
Q2
$3.39M Buy
140,988
+91,604
+185% +$1.86M ﹤0.01% 1953
2014
Q1
$1.24M Hold
49,384
﹤0.01% 2520
2013
Q4
$1.12M Buy
49,384
+15,256
+45% +$308K ﹤0.01% 2603
2013
Q3
$773K Buy
+34,128
New +$787K ﹤0.01% 2764

Other funds holding PGEN

TIAA CREF Investment Management's PGEN Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Precigen (PGEN) stake by 4.3% in Q1 2019, buying an estimated $39.7K and bringing the position to 138,934 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

TIAA CREF Investment Management first reported a position in PGEN in Q3 2013 and has held it in 23 quarters since. The position peaked at $11.4M in Q2 2015. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2019.

  • TIAA CREF Investment Management held 138,934 shares of Precigen worth $731K as of Q1 2019.
  • TIAA CREF Investment Management bought 5,721 Precigen shares in Q1 2019, an estimated $39.7K.
  • Precigen made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2451 holding.
  • TIAA CREF Investment Management first reported a position in Precigen in Q3 2013 and has held it in 23 quarters since.
  • TIAA CREF Investment Management's Precigen position peaked at $11.4M in Q2 2015.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.